High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
NCT05072626 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-04-03
Summary
This study is a prospective, single center and observational open clinical study.
Conditions
- Biliary Atresia
- Infant
- Nutrition Support
- Medium-chain Triglyceride
Sponsors & Collaborators
-
Children's Hospital of Fudan University
lead OTHER
Principal Investigators
-
Tian Qian, M.D. PhD · Children's Hospital of Fudan University
Eligibility
- Max Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-11
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- China
Study Locations
More Related Trials
-
Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants
NCT02073071 ·Status: COMPLETED
-
Influence of Improved Formula on Fatty Acids and Mineral Metabolism in Infants
NCT02587702 ·Status: UNKNOWN ·Phase: NA
-
Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition
NCT02758834 ·Status: COMPLETED
-
The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 3)
NCT06913621 ·Status: NOT_YET_RECRUITING
-
Protocol for Feeding Intolerance in Preterm Infants
NCT05347706 ·Status: UNKNOWN ·Phase: NA
-
High Energy Formula Feeding in Infants With Congenital Heart Disease
NCT01850784 ·Status: UNKNOWN ·Phase: NA
-
Infant & Toddler Short Gut Feeding Outcomes Study
NCT01946503 ·Status: COMPLETED
-
Post-Discharge Growth and Development of Infants Who Received Targeted Fortification in the NICU
NCT04190875 ·Status: SUSPENDED
-
Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate
NCT01755481 ·Status: COMPLETED ·Phase: NA
-
Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula
NCT03276663 ·Status: COMPLETED ·Phase: NA
-
Tolerance and Development of Healthy, Term Infants
NCT00465764 ·Status: COMPLETED ·Phase: PHASE2
-
Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life
NCT02646969 ·Status: COMPLETED ·Phase: NA
-
Soy Exposure on Bone Development and Gut Microbiota
NCT05213780 ·Status: RECRUITING
-
Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula
NCT01370967 ·Status: COMPLETED
-
A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants
NCT03062761 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants
NCT00658905 ·Status: COMPLETED ·Phase: PHASE2
-
Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants:
NCT02913677 ·Status: COMPLETED ·Phase: NA
-
Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants
NCT03055052 ·Status: COMPLETED ·Phase: NA
-
Enteral Feeding in Infants With Duct Dependant Lesions.
NCT05117164 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of the Effects of Soy Exposure in Early Life on Bone Development and Gut Microbiota
NCT05763589 ·Status: ACTIVE_NOT_RECRUITING
-
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
NCT02943746 ·Status: COMPLETED ·Phase: NA
-
Causes and Underlying Factors of Faltering Growth Among Infants
NCT03283215 ·Status: UNKNOWN
-
Acceptability and Tolerance Study of a Low Calorie Peptide Based Paediatric Tube Feed Formula.
NCT03718208 ·Status: COMPLETED ·Phase: NA
-
Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding
NCT03017664 ·Status: COMPLETED
-
Evaluation of A Partially Hydrolyzed in Improving FGIDs Symptoms
NCT03390309 ·Status: WITHDRAWN ·Phase: NA